Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SQLE | Q14534 | 5/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.31 |
| ▸ | FNTA | P49354 | 1/20 | 0.31 |
| ▸ | FNTB | P49356 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16294982 | 1.00 | SQLE (0.39) | SQLEHPGDALOX15CYP1A1CYP1B1 | |
| SCHEMBL21986504 | 1.00 | SQLE (0.39) | SQLEHPGDALOX15CYP1A1CYP1B1 | |
| SCHEMBL18436365 | 0.91 | CYP1A1 (0.40) | SQLEHPGDALOX15CYP1A1CYP1B1 | |
| SCHEMBL17822153 | 0.84 | SQLE (0.36) | SQLEHPGDALOX15KMT2AKDM1A | |
| SCHEMBL17822152 | 0.84 | SQLE (0.36) | SQLEHPGDALOX15KMT2AKDM1A | |
| SCHEMBL17208654 | 0.81 | ALOX15 (0.45) | SQLEALOX15CYP1A1CYP1B1KMT2A | |
| SCHEMBL18686407 | 0.81 | KMT2A (0.63) | SQLEALOX15KMT2AALDH1A1GGPS1 | |
| SCHEMBL16671129 | 0.81 | SQLE (0.46) | SQLEALOX15CYP1A1CYP1B1KMT2A | |
| SCHEMBL16671131 | 0.81 | SQLE (0.46) | SQLEALOX15CYP1A1CYP1B1KMT2A | |
| SCHEMBL18116630 | 0.79 | ALOX15 (0.46) | SQLEALOX15CYP1A1CYP1B1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 344 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12589377-B2 | Encapsulated composition comprising core-shell microcapsules and process for its preparation | GIVAUDAN SA (CH) | 2026-03-31 | — | — | US | claimed |
| US-12559703-B2 | Fragrance composition | GIVAUDAN SA (CH) | 2026-02-24 | — | — | US | claimed |
| EP-3325588-B1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2025-04-16 | — | — | EP | claimed |
| EP-4514477-A1 | FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE | Firmenich SA (CH) | 2025-03-05 | — | — | EP | claimed |
| WO-2024213536-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2024-10-17 | — | — | WO | claimed |
| US-20240238177-A1 | USE OF VOLATILE COMPOUNDS TO MODULATE THE PERCEPTION OF FLORAL MUGUET | FIRMENICH SA (CH) | 2024-07-18 | — | — | US | claimed |
| US-20240050335-A1 | A SYNERGISTIC PERFUMING COMPOSITION | FIRMENICH & CIE (CH) | 2024-02-15 | — | — | US | claimed |
| US-20240043770-A1 | A SYNERGISTIC PERFUMING COMPOSITION | FIRMENICH & CIE (CH) | 2024-02-08 | — | — | US | claimed |
| WO-2023247599-A1 | FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE | FIRMENICH SA (CH) | 2023-12-28 | — | — | WO | claimed |
| US-20230399590-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | SA, GIVAUDAN (CH) | 2023-12-14 | — | — | US | claimed |
| US-20190218476-A1 | FRAGRANCE COMPOSITIONS | GIVAUDAN SA (CH) | 2019-07-18 | — | — | US | claimed |
| CN-109963547-A | Deodorant comprising salts of carboxylic acids and aluminium chlorohydrate | 奇华顿股份有限公司 | 2019-07-02 | — | — | CN | claimed |
| WO-2018087148-A1 | DEODORANT COMPRISNG A ZINC CARBOXYLATE SALT AND ALUMINIUM CHLOROHYDRATE | GIVAUDAN SA (CH) | 2018-05-17 | — | — | WO | claimed |
| WO-2018050721-A1 | FRAGRANCE COMPOSITIONS | GIVAUDAN SA (CH) | 2018-03-22 | — | — | WO | claimed |
| US-20170327769-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS AND THEIR USE AS FRAGRANCE INGREDIENTS | GIVAUDAN S.A. (CH) | 2017-11-16 | — | — | US | claimed |
| EP-3230245-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS AND THEIR USE AS FLAGRANCE INGREDIENTS | Givaudan SA (CH) | 2017-10-18 | — | — | EP | claimed |
| EP-3149135-A2 | PERFUME COMPOSITIONS | Givaudan S.A. (CH) | 2017-04-05 | — | — | EP | claimed |
| US-20170073614-A1 | Perfume Compositions | GIVAUDAN SA (CH) | 2017-03-16 | — | — | US | claimed |
| WO-2016091895-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS AND THEIR USE AS FLAGRANCE INGREDIENTS | GIVAUDAN SA (CH) | 2016-06-16 | — | — | WO | claimed |
| WO-2015181257-A2 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2015-12-03 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12589377-B2 | Encapsulated composition comprising core-shell microcapsules and process for its preparation | CUTA, EXOC1, EXOSC10 | SQLE 2535/4885HPGD 3204/4885ALOX15 2323/4885 |
| US-12559703-B2 | Fragrance composition | DHCR24, OPRD1, OR10J3 | SQLE 211/4885HPGD 238/4885ALOX15 40/4885 |
| US-20170327769-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS AND THEIR USE AS FRAGRANCE INGREDIENTS | C5, C9, DHCR24 | SQLE 526/4885HPGD 175/4885ALOX15 50/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.